The risk for major adverse cardiovascular events is a recognized, important complication reported among patients with ANCA-associated vasculitis.

In a recent study, ticagrelor was found to be noninferior to prasugrel for a composite of ischemic events including death, ...

STEMI patients without standard modifiable CV risk factors face higher 30-day mortality compared with those with at least 1 risk factor.

The elderly account for the majority of medical spending in many countries, raising concerns about potentially unnecessary spending, especially during the final months of life. Using a well-defined ...

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...

In patients with ST-segment elevation myocardial infarction (STEMI) with multivessel coronary artery disease, the time at which complete revascularization of nonculprit lesions should be performed ...

Researchers at Kumamoto University have discovered that behavioral changes during the COVID-19 pandemic-particularly widespread mask-wearing-may have reduced the risk of certain types of heart attacks ...

Cardiovascular disease (CVD) remains the leading cause of mortality globally and in India. We routinely screen for ...

HPV is hypothesized to affect vascular inflammation and atherosclerosis, researchers say ...